Evidence map›Paper›PMID 42100485›Full record

ArticleFrontiers in aging neuroscience2026

Feasibility study of differentiating patients with levodopa-induced dyskinesia using cerebellar gray and white matter radiomics features from 3DT1WI images.

Yi Chen, Yini Chen, Andong Lin, Li Ding, Linyou Wang, Zhelin Xia, Rujia Wang

Abstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yi Chen *Department of Pharmacy, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, China.
Yini Chen *Department of Radiology, Taizhou Municipal Hospital, Taizhou, China.
Andong LinDepartment of Neurology, Taizhou Municipal Hospital, Taizhou, China.
Li DingDepartment of Pharmacy, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, China.
Linyou WangDepartment of Pharmacy, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, China.
Zhelin Xia *Department of Pharmacy, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, China.
Rujia Wang *Department of Pharmacy, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Levodopa therapy effectively treats Parkinson's disease (PD) motor symptoms but causes Levodopa-Induced Dyskinesia (LID) in some patients long-term. Cerebellar changes exist in LID cases; however, radiomics models based on this region haven't been evaluated for diagnostic use. We built diagnostic model using cerebellar structural radiomics from 3D T1WI to non-invasively diagnose LID. Methods: In this study, we retrospectively collected 3D T1WI data from the Parkinson's Progression Markers Initiative (PPMI) database, including data from 69 LID patients and 142 non-LID (N-LID) patients. These data were randomly split into a training set and a testing set at an 8:2 ratio. Using Fastsurfer segmentation, we identified four regions of interest (ROIs) corresponding to the left and right cerebellar gray matter and white matter. Python scripts were employed to independently extract radiomic features from each ROI. Subsequent steps involved feature selection and model construction. After selecting the optimal model, its performance was evaluated and validated. Finally, the SHAP method was used for model visualization. Results: Ultimately, the most representative 13 radiomic features were used for modeling. The model built based on the XGBoost algorithm achieved an AUC value of 0.962 on the training set and 0.849 on the testing set. Conclusion: The radiomic model extracted from the cerebellar gray and white matter effectively distinguishes between LID and N-LID patients. It offers a novel perspective on the heterogeneous characteristics of LID patients, significantly enhancing diagnostic performance and providing auxiliary support for clinical diagnosis.

Indexed as

cerebellumlevodopa-induced dyskinesiaMRIParkinson’s diseaseradiomics

Identifiers

PMID42100485
PMCPMC13143927

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.